Willis: Food industry faces mounting risks and falling confidence in risk management in 2026

Food safety and health risks are rising sharply: 45% of companies cite them as a top risk in 2026, up from 29% in 2024. The report links the increase to growing concern over ultra-processed foods and higher litigation exposure, implying cautious outlooks for affected food and beverage firms.

Analysis

The market implication is not an immediate demand collapse; it is a gradual re-rating of the most litigation-prone processed-food franchises as investors assign a higher probability to reserve builds, reformulation spend, and marketing restrictions. That tends to hit low-growth staples hardest because even modest legal uncertainty can compress multiples when organic growth is already scarce. The second-order winner set is healthier-perception retailers and private-label-heavy grocers, which can capture share without needing to fight the same liability overhang.

The consensus risk is to treat this as broad ESG noise. In practice, the exposure is highly idiosyncratic: companies with heavier child-targeted marketing, longer ingredient labels, or legacy product portfolios face a much steeper path to defense costs and settlement drag than the sector average. For WTW, the near-term P&L read-through is limited, but multi-monthly risk-management demand should improve as clients seek product-liability mapping, policy renewal advice, and litigation scenario work.

Catalyst timing is asymmetric: headlines can move stocks in days, but meaningful earnings impact shows up over 1-3 quarters through higher legal expense and potentially slower promotion spend. Over 6-18 months, the bigger issue is multiple compression if the litigation regime broadens beyond a few names into a portfolio-level concern for staple managers. The thesis is falsified if companies pre-announce immaterial reserve needs, maintain guidance, and the next two quarters show no uplift in legal accruals or reformulation capex.

Key Decisions for Investors

• Short a basket of exposed packaged-food names vs. XLP or PBJ over the next 1-3 months; best risk/reward is in names with weak growth and heavy processed-food mix. Cover if the basket outperforms XLP by ~5% or if Q3 commentary shows no reserve buildup.
• Long COST or SFM against short KHC over 3-6 months as a cleaner way to express the 'healthier basket wins' trade. The long leg benefits from consumer substitution without bearing the same litigation overhang.
• Treat WTW as a watch item, not a high-conviction long: only buy on pullbacks if brokerage commentary confirms higher demand for product-liability and risk advisory work. Otherwise, the article is not enough to underwrite a standalone position.
• If litigation headlines intensify, add put spreads on the most exposed staple names rather than outright shorts to limit carry costs; thesis weakens if the next earnings cycle shows no legal accrual step-up.